EUVIMEDEUVIMED entdecken
Vergleichsstudie

Methylation test versus dual staining in the triage of HR-HPV positive women – pilot data from cervical cancer screening

M Bartošová, I Kinkorová Luňáčková, J Bouda iD, K Černá iD, N Janovská iD, J Martínková Němcová iD

Česká gynekologie · 22.10.2026 · 91 (5) · 357-362

DOI: 10.48095/cccg2026357 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Česká gynekologie, online erschienen am 23.10.2026. Verfasst von M Bartošová und 5 weiteren Autor:innen. Hauptthemen laut MEDLINE: DNA Methylation, Uterine Cervical Neoplasms, Papillomavirus Infections, Human Papillomavirus Viruses.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Introduction of high-risk human papillomavirus (HR-HPV) testing into cervical cancer screening increases the detection of high-grade cervical lesions, but also identifies women with transient HR-HPV infections who are at a low risk of progression. To improve risk stratification, biomarkers that can be assessed from the same cervical sample used for HPV testing may be employed, particularly p16/Ki-67 dual-stain cytology and host-cell DNA methylation analysis. Dual staining identifies cells showing HPV-induced transforming activity, but may not fully capture the biological variability of either the host or the HPV infection. Methylation testing reflects epigenetic changes associated with persistent HR-HPV infection and biologically advanced cervical lesions that may therefore provide a more direct indication of the short-term risk of lesion progression.

Objective

To compare performance of p16/Ki-67 dual staining and DNA methylation analysis for risk stratification of HR-HPV-positive women.

Methods

The study included 44 HR-HPV-positive women (median age, 35 years) participating in the Czech cervical cancer screening program who underwent cervical biopsy or conization. Histologically confirmed HSIL/AIS was diagnosed in 52% of cases. Results of both triage methods were evaluated according to age, HPV genotype, and histological findings.

Results

The two methods showed concordant results in approximately 60% of cases, with the highest concordance observed in women older than 35 years. Among women aged 35 years or younger, discordant results were more frequent, most commonly consisting of positive dual staining combined with a negative methylation test. High concordance between the two methods was observed in HPV16-associated lesions, whereas among infections with other HR-HPV genotypes, positive dual staining accompanied by a negative methylation result was more common.

Conclusion

These findings suggest that methylation testing may be particularly useful for the triage of younger HR-HPV-positive women, potentially helping to reduce unnecessary referrals and invasive procedures without compromising the detection of clinically relevant cervical lesions. The findings of this pilot study are currently being validated in a larger prospective study conducted in collaboration with a specialized colposcopy clinic. Key words: cervical cancer screening – HPV testing – DNA methylation – p16/Ki-67 dual staining – triage of HR-HPV-positive women

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DNA MethylationUterine Cervical NeoplasmsPapillomavirus InfectionsHuman Papillomavirus VirusesHumansFemaleAdultPilot ProjectsTriageEarly Detection of CancerKi-67 AntigenCyclin-Dependent Kinase Inhibitor p16

Stichwörter der Autor:innen

DNA methylationHPV testingcervical cancer screeningp16/Ki-67 dual stainingtriage of HR-HPV-positive women

Substanzen

Ki-67 AntigenCyclin-Dependent Kinase Inhibitor p16

Autor:innen und Institutionen

ORCID-Profile: J Bouda, K Černá, N Janovská, J Martínková Němcová

Zitieren

APA

Bartošová, M., Kinkorová Luňáčková, I., Bouda, J., Černá, K., Janovská, N., & Martínková Němcová, J. (2026). Methylation test versus dual staining in the triage of HR-HPV positive women – pilot data from cervical cancer screening. Česká gynekologie, 91(5), 357-362. https://doi.org/10.48095/cccg2026357

Vancouver

Bartošová M, Kinkorová Luňáčková I, Bouda J, Černá K, Janovská N, Martínková Němcová J. Methylation test versus dual staining in the triage of HR-HPV positive women – pilot data from cervical cancer screening. Česká gynekologie. 2026;91(5):357-362. doi:10.48095/cccg2026357

BibTeX
@article{Bartoov2026,
  author = {Bartošová, M and Kinkorová Luňáčková, I and Bouda, J and Černá, K and Janovská, N and Martínková Němcová, J},
  title = {Methylation test versus dual staining in the triage of HR-HPV positive women – pilot data from cervical cancer screening},
  journal = {Česká gynekologie},
  year = {2026},
  volume = {91},
  number = {5},
  pages = {357--362},
  doi = {10.48095/cccg2026357}
}
Kostenlos starten →